新股申购

Search documents
股票申购新股需要什么条件?一文读懂
Sou Hu Cai Jing· 2025-05-16 08:30
还有一点也很重要,那就是你得在规定的时间内进行申购。新股申购可不是随时都能进行的,它有固定的申购时间。一般来说,是在交易日的上午9:30到 11:30,下午13:00到15:00。要是你错过了这个时间段,那可就没机会申购这只新股。所以,大家一定要留意新股的申购时间,提前做好准备。 不同的新股可能还会有一些特殊的要求。比如说,有些新股可能会对投资者的风险承受能力有要求。要是你的风险承受能力比较低,可能就没法申购一些风 险较高的新股。还有一些新股可能会对投资者的投资经验有要求,比如要求你在股市里有一定的投资年限。像科创板、北交所的新股申购,必须开通相应交 易权限才可以。 朋友们!在股票投资这个充满机遇和挑战的世界里,申购新股可是不少人眼里的"香饽饽"。为啥这么说呢?因为新股上市后,常常会有不错的涨幅,要是能 申购成功,那可就有机会赚上一笔。不过,这新股可不是你想申购就能申购的,得满足一定的条件才行。今天咱就来唠唠,股票申购新股到底需要啥条件。 首先你得有个股票账户。这就好比你要进一家俱乐部,得先有会员卡一样。股票账户就是你在股市里的"身份证",有了它,你才能在股市里进行各种操作, 包括申购新股。现在开户也挺方便的 ...
资金流向周报丨东方财富、新易盛、胜宏科技上周获融资资金买入排名前三
2 1 Shi Ji Jing Ji Bao Dao· 2025-05-12 04:26
一、证券市场回顾 南财金融终端数据显示,上周(5月6日-5月9日,下同),上证综指周内上涨1.92%,收于3342.0点,最高3359.73点;深证成指周内上涨2.29%,收于10126.83 点,最高10248.98点;创业板指周内上涨3.27%,收于2011.77点,最高2036.1点。在全球市场中,主要指数有涨有跌。纳斯达克综指下跌0.27%,道琼斯工业 指数下跌0.16%,标普500下跌0.47%。亚太地区,恒生指数上涨1.61%,日经225指数上涨1.83%。 二、新股申购情况 上周有3只新股发行,详情见下表: | 股票代码 | 股票简称 | 申购日期 | | --- | --- | --- | | 301595.SZ | 太力科技 | 20250508 | | 603014.SH | 威高血净 | 20250508 | | 688755.SH | 汉邦科技 | 20250507 | 三、融资融券情况 上周共有16条开始执行回购公告,其中执行金额最多的5条公告为: | 证券代码 | 证券简称 | | --- | --- | | 601877 | 正泰电器 | | 002145 | 中核钛白 | | ...
资金流向周报丨东方财富、新易盛、胜宏科技上周获融资资金买入排名前三,东方财富获买入超48亿元
2 1 Shi Ji Jing Ji Bao Dao· 2025-05-12 03:56
Market Overview - The Shanghai Composite Index increased by 1.92% to close at 3342.0 points, with a weekly high of 3359.73 points [1] - The Shenzhen Component Index rose by 2.29% to 10126.83 points, reaching a peak of 10248.98 points [1] - The ChiNext Index saw a 3.27% increase, closing at 2011.77 points, with a maximum of 2036.1 points [1] - In the global market, the Nasdaq Composite fell by 0.27%, the Dow Jones Industrial Average decreased by 0.16%, and the S&P 500 dropped by 0.47% [1] - In the Asia-Pacific region, the Hang Seng Index rose by 1.61%, and the Nikkei 225 increased by 1.83% [1] New Stock Issuance - Three new stocks were issued last week: Tai Li Technology (301595.SZ), Weigao Blood Products (603014.SH), and Hanbang Technology (688755.SH) [2] Margin Trading - The total margin trading balance in the Shanghai and Shenzhen markets reached 1798.839 billion yuan, with a financing balance of 1787.274 billion yuan and a securities lending balance of 11.565 billion yuan [3] - The margin trading balance increased by 17.394 billion yuan compared to the previous week [3] - The Shanghai market's margin trading balance was 917.212 billion yuan, up by 7.436 billion yuan, while the Shenzhen market's balance was 881.627 billion yuan, increasing by 9.958 billion yuan [3] - A total of 3400 stocks had margin buying, with 34 stocks exceeding 1 billion yuan in buying amount, led by Dongfang Caifu, Xinyi Sheng, and Shenghong Technology [3][4] Fund Issuance - Four new funds were launched last week: Zhongyou Core Preferred Mixed C, Zhongyou Core Growth Mixed C, Zhongyou Core Theme Mixed C, and Zhongjin Cash Manager D [5] Company Buybacks - Sixteen companies announced share buybacks last week, with the highest amounts executed by Zhengtai Electric, Zhongke Huoxiang, Guangzi Group, Juguang Technology, and Ling Supervisory Selection [6][7] - The top three industries by buyback amount were electric equipment, electronics, and basic chemicals [7]
新股&北交所 2025年4月A股申购观点汇报
2025-05-12 01:48
Summary of Key Points from the Conference Call Industry Overview - The conference call discusses the performance and trends in the Chinese stock market, particularly focusing on new stock issuances, REITs (Real Estate Investment Trusts), and the North Exchange (北交所) market dynamics in April 2025. Key Insights and Arguments 1. **New Stock Issuance and Valuation** - April's new stock issuance PE valuation reached a 24-year low, averaging around 15 times, primarily due to the concentration of issuances in the main board and ChiNext, with no new stocks from the Sci-Tech Innovation Board [1][7] - New stocks were issued at an average discount of 42% compared to comparable companies, with a slight narrowing of the discount to about 4.2% [1][7] - The offline inquiry heat reached a 25-year high, with an average of 282 institutions participating in ChiNext and 7,800 participants in the main board [1][7] 2. **REITs Market Performance** - Public REITs saw a significant increase in offline subscription interest, with subscription multiples exceeding 200 times, leading to a very low winning rate [1][6] - The first-day price increase for REITs has been generally positive, with recent variations noted [1][6] - The total number of REITs issued reached 66, raising a cumulative amount of 172 billion yuan [1][16] 3. **North Exchange (北交所) Developments** - In April, the North Exchange had one new stock issuance with a 5% decrease in effective accounts to 430,000, and a subscription multiple of 2,417 times [1][9] - The average first-day increase for new stocks was 216%, maintaining a zero break-even status [1][9] - Strategic placement rules were revised to allow a higher proportion of strategic placements, increasing participation feasibility [1][22] 4. **Market Trends and Future Expectations** - The issuance pace of new stocks is expected to accelerate post-May, with an estimated 1 to 3 new stocks issued weekly, totaling close to 100 for the year [1][4] - The average financing scale for new stocks is projected to rise to 250 million yuan [1][25] - The overall market sentiment remains cautious due to seasonal factors and financial report updates affecting the issuance rhythm [1][3] 5. **Impact of Regulatory Changes** - The adjustment of insurance asset management and bank wealth management accounts from C-class to A-class has had a limited impact on offline subscriptions due to the large number of participants [1][5] - The strategic placement policy changes are expected to enhance long-term capital participation in the North Exchange [1][28] Additional Important Information - The REITs market showed a mixed performance in April, with infrastructure sectors like consumption and water operations performing well, while energy and industrial parks faced significant declines [1][10] - The average subscription amount required for new stock applications has decreased significantly, reflecting a shift in investor behavior [1][21] - The overall market dynamics indicate a trend towards lower-risk investments, with a notable absence of significant declines in new stock issuance returns since 2024 [1][30]
血液净化龙头、真空收纳袋生产商,两只新股今日申购 | 打新早知道
2 1 Shi Ji Jing Ji Bao Dao· 2025-05-07 23:14
Group 1: Tai Li Technology - Tai Li Technology focuses on new materials research and vacuum technology applications, offering a variety of home storage products and related functional materials [1][4] - The company is the exclusive supplier of compression bags for China's aerospace program, with products used in space 25 times, addressing risks associated with the vacuum environment [4] - Tai Li Technology has implemented a multi-channel strategy, transitioning from traditional distribution to primarily online sales, covering major platforms domestically and internationally [4] - The company has acknowledged past issues with "brushing" and "cashback for reviews," which have been rectified, and it has ceased such practices since 2022 [5] Group 2: Weigao Blood Purification - Weigao Blood Purification specializes in the research, production, and sales of medical products for blood purification, including dialysis machines and related products [5][6] - The company has a market share of 32.5% in the domestic blood dialysis market, leading the industry, and holds a 31.8% share in blood dialysis tubing [9] - Weigao Blood Purification has developed a neutral peritoneal dialysis solution in collaboration with a well-known international company, holding a 3.6% market share in the domestic peritoneal dialysis market [9] - The company plans to invest in various projects, including intelligent production and digital information technology platforms, with a total fundraising target of approximately 12.56 billion yuan [8]
5月7日投资提示:下次,还做套利人
集思录· 2025-05-06 14:44
Group 1 - The article discusses various companies' shareholder activities, including planned share reductions and increases [2] - Youzu Network's shareholders plan to reduce their holdings by up to 2.99% [2] - Huamao Technology's controlling shareholder intends to increase their stake by 100 million to 200 million yuan [2] - Tongyu Heavy Industry's actual controller will change from Zhuhai State-owned Assets Supervision and Administration Commission to Shandong State-owned Assets Supervision and Administration Commission, with a resumption of trading on May 7 [2] - Yunda Holdings' controlling shareholder also plans to increase their stake by 100 million to 200 million yuan [2] - The article mentions adjustments in convertible bonds, with Shouhua Convertible Bond not undergoing a bottom adjustment, while Yuxing and Shengxun Convertible Bonds will not be adjusted [2] - Hanbang Technology is mentioned in the context of new stock subscriptions on the Shanghai and Shenzhen exchanges [2]
节后首周3股将申购!血液净化、真空收纳龙头在列
Zheng Quan Shi Bao· 2025-05-05 12:42
Core Viewpoint - The A-share market will have three new stock subscriptions this week, including Hanbang Technology, Weigao Blood Purification, and Taili Technology, indicating a growing interest in innovative companies within the healthcare and technology sectors [1] Group 1: Hanbang Technology - Hanbang Technology is a leading supplier of chromatography separation and purification equipment in China, particularly in the production-grade small molecule drug separation market, holding a market share of approximately 39.2% [3] - The company has developed a comprehensive product matrix for both small and large molecule drug separation and purification equipment, catering to industrial production and laboratory research [2] - Hanbang Technology's revenue for 2022, 2023, and 2024 is projected to be 482 million, 619 million, and 691 million yuan, respectively, with net profits of 39 million, 51 million, and 79 million yuan [3] Group 2: Weigao Blood Purification - Weigao Blood Purification focuses on the research, production, and sales of medical products for blood purification, with a diverse product line including blood dialysis machines and accessories [4] - The company holds a leading market share in the domestic blood dialysis sector, with 32.5% in blood dialysis devices and 31.8% in blood dialysis tubing [4] - Revenue projections for Weigao Blood Purification for 2022, 2023, and 2024 are 3.426 billion, 3.532 billion, and 3.604 billion yuan, respectively, with net profits of 315 million, 442 million, and 449 million yuan [5] Group 3: Taili Technology - Taili Technology specializes in new material research and vacuum technology applications, being the exclusive supplier of compression bags for China's aerospace sector [6] - The company has implemented a multi-channel sales strategy, transitioning from traditional distribution to a primarily online sales model, while also maintaining strong offline retail partnerships [7] - Revenue forecasts for Taili Technology for 2022, 2023, and 2024 are 638 million, 835 million, and 1.02 billion yuan, respectively, with net profits of 59 million, 85 million, and 88 million yuan [7]
节后首周3股将申购!血液净化、真空收纳龙头在列
证券时报· 2025-05-05 12:27
Core Viewpoint - The article discusses the upcoming IPOs of three companies in the A-share market, highlighting their business models, market positions, and financial projections. Group 1: Hanbang Technology - Hanbang Technology is a leading supplier of chromatography separation and purification equipment in China, particularly in the production-grade small molecule drug separation market [2][3] - The company has a diverse product matrix, including small and large molecule drug separation equipment, and has established a strong customer base with over 2,000 clients, including major pharmaceutical companies [4] - Financial projections indicate revenues of 482 million yuan, 619 million yuan, and 691 million yuan for 2022, 2023, and 2024 respectively, with net profits of 39 million yuan, 51 million yuan, and 79 million yuan [4] Group 2: Weigao Blood Purification - Weigao Blood Purification focuses on the research, production, and sales of medical products for blood purification, with a comprehensive product line including hemodialysis devices and peritoneal dialysis solutions [6][7] - The company holds significant market shares in various segments, including 32.5% in hemodialysis devices and 31.8% in hemodialysis tubing, ranking first in the industry [6][7] - Revenue projections for Weigao indicate 3.426 billion yuan, 3.532 billion yuan, and 3.604 billion yuan for 2022, 2023, and 2024 respectively, with net profits of 315 million yuan, 442 million yuan, and 449 million yuan [7] Group 3: Taili Technology - Taili Technology specializes in new materials and vacuum technology applications, being the exclusive supplier of aerospace vacuum compression bags in China [8][9] - The company has implemented a multi-channel sales strategy, transitioning to a primarily online sales model while maintaining partnerships with major retailers globally [9] - Financial forecasts show revenues of 638 million yuan, 835 million yuan, and 1.02 billion yuan for 2022, 2023, and 2024 respectively, with net profits of 59 million yuan, 85 million yuan, and 88 million yuan [10]
新股上市首日涨24倍!揭秘:如何申购新股才更容易中签?
Sou Hu Cai Jing· 2025-05-05 03:41
朋友们,今天可真是见证了股市的奇迹。某家新股——强邦新材,上市的第一天竟然暴涨了整整24倍!这股市里的意外惊喜,仿佛一颗重磅炸弹,狠狠地撼 动了我们的心脏。咱们都知道,申购新股如果能中签,简直是像一夜之间变富一样,财富的涨幅让人目瞪口呆。比如说,这次强邦新材的中签,500股就能 赚到接近11万元,真是让人眼红得不行! 不过,朋友们,想要轻松坐享其成,光靠一双手指头点击几下可不行,打新股也得有点技巧才行。今天,我们就来深度探讨一下如何提高新股申购的中签 率,让你也能在股市的红利中分一杯羹。 首先,要知道,新股申购其实是一个很简单的过程,简单到就像填写一张申请表,但实际操作起来,得有些规矩。A股市场上有个不成文的"铁律",那就是 一旦你能够中签新股,基本上就能赚到一笔不小的财富。这是因为新股在刚上市时,由于供给稀缺,加之市场的疯狂炒作,股价往往会有一段时间的疯涨。 于是,打新股便成了许多投资者的首选,谁不想轻松赚到这笔钱呢? 开通这些权限并不复杂,通常在券商的APP上操作几下就可以完成。只不过,在开通之前,你需要满足一定的条件,比如资金量、交易经验等,做好这些准 备,才能更好地提升你的申购机会。 第三招:参与网下 ...
A股:高价新股天有为上市交易,中签股民获惊喜,但涨幅有点少!
Sou Hu Cai Jing· 2025-04-24 23:48
就在高价新股天有为即将敲响上市钟声的前夜,那些幸运中签并决定缴款的股民们心中想必充满了激动与期待。这只股票的发行价高达93.50元,这是今年 新股发行的新高点。之前,不少新股在首日上市时都曾创下惊人的涨幅,仿佛每一次打新都是财富增长的捷径。然而,天有为的到来带来了前所未有的考验 ——它那令人高仰的高价标签,在市场中的表现依旧是个未知数。 对于这些投资者来说,面对如此高的发行价,心中既有对未来的憧憬,也有着难以避免的担忧。毕竟,在股市这个变幻莫测的战场上,过去的经验虽能提供 一些指引,却无法保证未来的结果。特别是当涉及到像天有为这样价格达到历史新高的新股时,其上市后的表现将是对市场承受能力的一次大考。 随着天有为开盘钟声的敲响,那令人揪心的担忧和无尽的忧虑瞬间随风飘散。天有为以140元的高价开盘,较之93.50元的发行价高开了49.73%,这一表现无 疑给所有中签并选择缴款的股民们送上了一份惊喜大礼。假设这些幸运儿在开盘时果断卖出,那么他们的打新收益将达23250元,超过2万元的新股利润,在 任何投资者眼中都应该是一笔相当不错的收入吧? 对于那些参与了此次打新的股民来说,这不仅仅是数字上的胜利,更是一次心灵上的 ...